ArticleRSC advances2025

A multimodal caffeic acid-derived alkyl-amide antidiabetic agent: targeting α-glucosidase, α-amylase, oxidative stress, and protein glycation.

Karthika Kannan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.